GINS4
DNA replication complex GINS protein SLD5
Also known as: MGC14799, SLD5, SLD5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BRT9
- Gene
- GINS4
- Ensembl
- ENSG00000147536
- Chromosome
- 8
- Canonical length
- 223 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Centrosome
OverviewNCBI Gene
The yeast heterotetrameric GINS complex is made up of Sld5, Psf1 (GINS1; MIM 610608), Psf2 (GINS2; MIM 610609), and Psf3 (GINS3; MIM 610610). The formation of the GINS complex is essential for the initiation of DNA replication in yeast and Xenopus egg extracts (Ueno et al., 2005 [PubMed 16287864]). See GINS1 for additional information about the GINS complex.[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
223 residues, UniProt reviewed canonical sequence.
>Q9BRT9|GINS4
1 MTEEVDFLGQ DSDGGSEEVV LTPAELIERL EQAWMNEKFA PELLESKPEI VECVMEQLEH
61 MEENLRRAKR EDLKVSIHQM EMERIRYVLS SYLRCRLMKI EKFFPHVLEK EKTRPEGEPS
121 SLSPEELAFA REFMANTESY LKNVALKHMP PNLQKVDLFR AVPKPDLDSY VFLRVRERQE
181 NILVEPDTDE QRDYVIDLEK GSQHLIRYKT IAPLVASGAV QLILocalizationUniProt · AlphaFold · HPA
Whether an antibody against GINS4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 5.7 nTPM
Expression across tissuesHPA
Tissue
- thymus: 5.7 nTPM
- tonsil: 5.6 nTPM
- bone marrow: 5.4 nTPM
- lymph node: 4.7 nTPM
- appendix: 3.7 nTPM
- rectum: 2.8 nTPM
Single-cell type
- neutrophils: 36 nCPM
- megakaryocyte progenitors: 28 nCPM
- monocyte progenitors: 26 nCPM
- erythrocyte progenitors: 26 nCPM
- extravillous trophoblasts: 16 nCPM
- differentiating spermatogonia: 14 nCPM
Immune cell
- T-reg: 3.6 nTPM
- naive B-cell: 2.8 nTPM
- plasmacytoid DC: 2.8 nTPM
- memory CD4 T-cell: 2.5 nTPM
- neutrophil: 1.6 nTPM
- gdT-cell: 1.5 nTPM
Brain region
- white matter: 7 nTPM
- medulla oblongata: 5.5 nTPM
- cerebellum: 5.4 nTPM
- cerebral cortex: 5 nTPM
- basal ganglia: 4.9 nTPM
- pons: 4.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.08
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.54
- DepMap mean gene effect
- -1.39
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- DNA replication
- DNA-templated DNA replication
- double-strand break repair via break-induced replication
- inner cell mass cell proliferation
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GINS subunit, domain A
- GINS, helical bundle-like domain superfamily
- GINS complex protein helical bundle domain
- GINS complex subunit Sld5
- DNA replication complex GINS protein SLD5, C-terminal
- GINS complex protein Sld5, alpha-helical domain
- DNA replication complex GINS protein SLD5 C-terminus
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GINS4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GINS4 as an antibody target. Whether an autoantibody or antibody against GINS4 could matter depends on whether native GINS4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GINS4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GINS4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...